for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Innophos Holdings, Inc.

IPHS.OQ

Latest Trade

33.34USD

Change

-1.10(-3.19%)

Volume

160,670

Today's Range

33.10

 - 

34.70

52 Week Range

22.62

 - 

46.43

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
34.44
Open
34.70
Volume
160,670
3M AVG Volume
1.95
Today's High
34.70
Today's Low
33.10
52 Week High
46.43
52 Week Low
22.62
Shares Out (MIL)
19.69
Market Cap (MIL)
671.84
Forward P/E
20.38
Dividend (Yield %)
5.57

Next Event

Q3 2019 Innophos Holdings Inc Earnings Release

Latest Developments

More

Innophos Holdings Inc Reports Second-Quarter 2019 Results

Innophos Holdings Posts Q1 Adjusted Earnings Per Share of $0.57

Innophos Holdings Q4 Adjusted Earnings Per Share $0.54

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Innophos Holdings, Inc.

Innophos Holdings, Inc. is an international producer of specialty ingredient solutions that deliver for the food, health, nutrition and industrial markets. The Company’s segments include Food, Health and Nutrition, Industrial Specialties and Other. It offers a range of product categories, such as asphalt, catalyst, fertilizer salts, liquid phosphate, phosphate salt, phosphoric acid, polyphosphoric acid, sodium bicarbonate, and food blends. The Company is blends and formulates phosphate, mineral and botanical-based ingredients to help its customers offer products that are tasty, healthy, nutritious and economical. The Company, through its subsidiaries, Novel Ingredients, LLC and NutraGenesis LLC, is expanding its food, health and nutrition platform. The Company has manufacturing operations across the United States, in Canada, Mexico and China.

Industry

Chemical Manufacturing

Contact Info

259 Prospect Plains Rd

+1.609.4952495

http://www.innophos.com/

Executive Leadership

Kim Ann Mink

Chairman of the Board, President, Chief Executive Officer

Hermanus Kieftenbeld

Chief Financial Officer, Senior Vice President

Mark Feuerbach

Interim Chief Financial Officer

Sherry Duff

Senior Vice President, Chief Marketing and Technology Officer

Joshua S. Horenstein

Senior Vice President, Chief Legal and Human Resources Officer and Corporate Secretary

Key Stats

2.50 mean rating - 2 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2016

0.7K

2017

0.7K

2018

0.8K

2019(E)

0.7K
EPS (USD)

2016

2.550

2017

2.460

2018

2.280

2019(E)

2.190
Price To Earnings (TTM)
31.61
Price To Sales (TTM)
0.88
Price To Book (MRQ)
2.00
Price To Cash Flow (TTM)
10.38
Total Debt To Equity (MRQ)
97.29
LT Debt To Equity (MRQ)
97.29
Return on Investment (TTM)
3.00
Return on Equity (TTM)
2.59

Latest News

BRIEF-Innophos Holdings Reports Qtrly Loss Per Share $0.58

* INNOPHOS HOLDINGS, INC. REPORTS FOURTH-QUARTER AND FULL-YEAR 2017 RESULTS

BRIEF-Innophos Appoints Nicolas Meyrial As Vice President, Commercial – Nutrition

* INNOPHOS APPOINTS NICOLAS MEYRIAL AS VICE PRESIDENT, COMMERCIAL – NUTRITION Source text for Eikon: Further company coverage:

BRIEF-Innophos buys nutragenesis to complement its branded food, health and nutrition portfolio

* Innophos acquires nutragenesis to complement its branded food, health and nutrition portfolio

BRIEF-INNOPHOS HOLDINGS REPORTS Q3 ‍DILUTED EPS $0.58​

* COMPANY INCREASED ITS FULL YEAR 2017 SALES GUIDANCE, AND MAINTAINED ITS ADJUSTED EBITDA

BRIEF-Innophos Holdings says on July 28, unit entered agreement, plan of merger

* Innophos holdings - on July 28, co, unit of co, Gennx Novel Holding, Gennx Novel representative entered into agreement, plan of merger - SEC filing

BRIEF-GenNX360 Capital Partners enters agreement to sell Novel Ingredients to Innophos Holdings Inc

* GenNX360 capital partners enters agreement to sell Novel Ingredients to Innophos Holdings Inc Source text for Eikon: Further company coverage:

BRIEF-Innophos Holdings Inc Q2 earnings per participating share $0.57

* Innophos Holdings, Inc. Reports second-quarter 2017 results

BRIEF-Innophos to acquire Novel Ingredients to create a nearly $0.5 bln food, health and nutrition platform

* Innophos to acquire novel ingredients to create a nearly $0.5 billion food, health and nutrition platform

BRIEF-Innophos Holdings Q1 adjusted earnings per share $0.59

* Innophos Holdings Inc - sales comparables in q2 are expected to improve sequentially, but still be down approximately 5% year-over-year

BRIEF-Innophos Holdings reiterates Q1 2017 expectations and 2017 guidance

* Innophos holdings inc - targeting $1.25 billion revenue and 20% adjusted ebitda by 2022

BRIEF-Innophos appoints Kim Ann Mink as chairman of the board

* Innophos board of directors appoints dr. Kim ann mink as chairman of the board Source text for Eikon: Further company coverage:

BRIEF-Innophos secures long-term viability of Geismar phosphoric acid facility

* Innophos secures long-term viability of geismar phosphoric acid facility

BRIEF-Innophos Holdings declares quarterly dividend

* Sets quarterly dividend of $0.48 per share Source text for Eikon: Further company coverage:

BRIEF-Innophos Holdings posts Q3 adj. earnings per share $0.75

* Q3 earnings per share view $0.65 -- Thomson Reuters I/B/E/S

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up